NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

Compare
3.5000 +0.4000 (+12.90%)
At close: 4:00 PM EDT
3.5100 +0.01 (+0.29%)
After hours: 6:05 PM EDT
Loading Chart for CLOV
DELL
  • Previous Close 3.1000
  • Open 3.0800
  • Bid 3.4700 x 2000
  • Ask 3.5400 x 2000
  • Day's Range 2.9900 - 3.5500
  • 52 Week Range 0.6060 - 3.5500
  • Volume 15,983,162
  • Avg. Volume 6,354,453
  • Market Cap (intraday) 1.741B
  • Beta (5Y Monthly) 2.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2400
  • Earnings Date Nov 4, 2024 - Nov 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.06

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 8/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV
267.65%
S&P 500
17.84%

1-Year Return

CLOV
159.26%
S&P 500
28.63%

3-Year Return

CLOV
54.84%
S&P 500
26.55%

5-Year Return

CLOV
65.24%
S&P 500
84.82%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

Annual
As of 8/20/2024
  • Market Cap

    1.54B

  • Enterprise Value

    1.17B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.72

  • Price/Book (mrq)

    4.75

  • Enterprise Value/Revenue

    0.56

  • Enterprise Value/EBITDA

    -0.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.92%

  • Return on Assets (ttm)

    -6.50%

  • Return on Equity (ttm)

    -36.85%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    -120.77M

  • Diluted EPS (ttm)

    -0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    379.05M

  • Total Debt/Equity (mrq)

    1.23%

  • Levered Free Cash Flow (ttm)

    2.19M

Research Analysis: CLOV

View More

Company Insights: CLOV

Research Reports: CLOV

View More

People Also Watch